Search Results - "Hulsebosch, S. E."

Re‐evaluation of the low‐dose dexamethasone suppression test in dogs by Lim, L., Hulsebosch, S. E., Gilor, C., Reagan, K. L., Kopecny, L., Maggiore, A. D., Phillips, K. L., Kass, P. H., Vernau, W., Nelson, R. W.

“…Objectives This study aims to re‐evaluate the low‐dose dexamethasone suppression test 8‐hour cortisol cut‐point for the diagnosis of hypercortisolism in dogs…”
Get full text

Evaluation of Canine Pancreas‐Specific Lipase Activity, Lipase Activity, and Trypsin‐Like Immunoreactivity in an Experimental Model of Acute Kidney Injury in Dogs by Hulsebosch, S.E., Palm, C.A., Segev, G., Cowgill, L.D., Kass, P.H., Marks, S.L.

“…Background Diagnosis of pancreatitis in dogs is complicated by extrapancreatic disorders that can alter the results of laboratory tests. Extrapancreatic…”
Get full text

Comparison of pharmacodynamics and pharmacokinetics of insulin degludec and insulin glargine 300 U/mL in healthy cats by Gilor, C., Culp, W., Ghandi, S., do Carmo Emidio e Silva, J.A., Ladhar, A., Hulsebosch, S.E.

“…Insulin glargine 300 U/mL (IGla-U300) and insulin degludec (IDeg) are synthetic insulin analogs designed as basal insulin formulations. In people, IGla-U300 is…”
Get full text